The global Neuroscience market size was valued at USD 35.9 Billion in 2024 and is anticipated to reach USD 48.0 Billion by 2033, exhibiting a CAGR of 3.1% during the forecast period 2025-2033. Market growth is driven by increasing prevalence of neurological disorders, significant investments in research and development, and technological advancements in neuroimaging tools. The expanding applications in neuroinformatics, rising aging populations, and supportive government policies further support the growth of this market.
Study Assumption Years
Neuroscience Market Key Takeaways
Sample Request Link:
https://www.imarcgroup.com/neuroscience-market/requestsample
Market Growth Factors
Increasing Prevalence of Neurological Disorders
The global rise in neurological conditions such as Alzheimer’s disease, Parkinson’s disease, and epilepsy is significantly driving neuroscience market growth. Alzheimer's cases are projected to reach 13 Million in the US by 2050. The aging population increases susceptibility to these disorders, resulting in rising demand for advanced diagnostics and treatments. The hospital sector is expected to observe the fastest growth due to increasing neurological admissions and expanded healthcare infrastructure.
Rising Investment in Neuroscience Research and Development
The field sees strong funding surges from both the public and private sectors. Investments span fundamental brain research and advanced technologies such as brain mapping and neural data integration. Key players in biotech and pharma are developing new drugs and therapies. Enhanced consumables like user-friendly patient monitors and injectors by companies such as B. Braun SE and GE Healthcare improve neurological care efficiency, accelerating scientific discovery and its clinical application.
Technological Advancements in Neuroimaging Tools
Neuroimaging technologies including MRI, PET, and EEG offer higher resolution, faster imaging, and improved data analysis through advanced algorithms. The innovations allow earlier and more precise detection and localization of brain abnormalities critical for effective treatment. Emerging neuro-microscopy with ultra-miniature electronic microscopes, developed by Danaher Corporation and Carl Zeiss AG, also aims to detect and potentially reverse neurological damage, thus expanding the capabilities of neuroscience research and clinical practice.
Market Segmentation
Breakup by Component:
Breakup by Technology:
Breakup by End User:
Breakup by Region:
Regional Insights
North America dominates the neuroscience market, accounting for the largest market share. This leadership is attributed to substantial investments in research and development, a high incidence of neurological disorders, and a well-established healthcare infrastructure. The United States serves as a hub for companies and research institutions that drive innovation and market growth. The Asia Pacific region is the fastest-growing market, supported by improved healthcare spending and government initiatives such as China's USD 746 Million China Brain Project launched in 2022.
Recent Developments & News
In 2021, Blackrock Neurotech announced a breakthrough with its wireless brain-computer interface (BCI) system, enabling real-time neural activity monitoring without wired connections, enhancing patient comfort during studies. In 2022, Kernel introduced Kernel Flow, a non-invasive brain recording device using time-domain functional near-infrared spectroscopy (TD-fNIRS) technology to capture brain activity with high spatial and temporal resolution, broadening applications in clinical and consumer neuroscience.
Key Players
Get Custom Market Research Report for Your Business:
https://www.imarcgroup.com/request?type=report&id=5133&flag=E
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302